ArticleInvestigational new drugs2011

A phase I dose-escalation, safety and pharmacokinetic study of the 2-methoxyestradiol analog ENMD-1198 administered orally to patients with advanced cancer.

Qing Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.